Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Argiris Symeonidis

Showing results (21-30 of 138) with videos related to

Pageof 14
Sort By:
Leukemia Research|August 2, 2011
Increased RANKL and IL-6 levels might result in high bone turnover in a case of a CD34+/CD117+/myeloperoxidase(+dim) acute myeloid leukemia presenting with severe hypercalcemia and lumbar spine fracturesNikolaos C Giannakoulas, Evangelos Terpos, Maria Palassopoulou, et al.
JSES Reviews, Reports, and Techniques|May 6, 2024
Delayed diagnosis of a primary diffuse large B-cell lymphoma of the humeral head, presenting as pathological fracture: a case report and review of the literatureAndreas Panagopoulos, Konstantina Solou, Argiris Symeonidis, et al.
British Journal of Haematology|September 9, 2004
Impaired generation of bone marrow CD34-derived dendritic cells with low peripheral blood subsets in patients with myelodysplastic syndromeIlina Micheva, Eleni Thanopoulou, Sotiria Michalopoulou, et al.
Oncology|February 17, 2005
Increased serum CA-15.3 levels in patients with megaloblastic anemia due to vitamin B12 deficiencyArgiris Symeonidis, Alexandra Kouraklis-Symeonidis, Dimitris Apostolopoulos, et al.
Clinical Nuclear Medicine|October 4, 2013
(99m)Tc sestamibi as a prognostic factor of response to first-line therapy and outcome in patients with malignant lymphomaTrifon J Spyridonidis, Panayota Matsouka, Argiris Symeonidis, et al.
JIMD Reports|October 14, 2014
Severe impairment of regulatory T-cells and Th1-lymphocyte polarization in patients with Gaucher diseaseChristos Sotiropoulos, George Theodorou, Constantina Repa, et al.
Gene|August 7, 2020
LRF/ZBTB7A conservation accentuates its potential as a therapeutic target for the hematopoietic disordersVasiliki Chondrou, Georgios S Markopoulos, George P Patrinos, et al.
Annals of Hematology|September 1, 2005
Inappropriately low erythropoietin response for the degree of anemia in patients with noninsulin-dependent diabetes mellitusArgiris Symeonidis, Alexandra Kouraklis-Symeonidis, Agathoklis Psiroyiannis, et al.
Dermatologic Therapy|February 17, 2021
Rare lobular capillary hemangioma associated with azacitidine in high-risk myelodysplastic syndrome patientKaterina Grafanaki, Alexandra Kourakli, Ilias Skeparnias, et al.
Hematology (Amsterdam, Netherlands)|January 20, 2017
Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western GreeceChristina Avgerinou, Ioanna Giannezi, Stela Theodoropoulou, et al.
Pageof 14

Showing results (21-30 of 138) with videos related to

Sort By:
Pageof 14
Leukemia Research|August 2, 2011
Increased RANKL and IL-6 levels might result in high bone turnover in a case of a CD34+/CD117+/myeloperoxidase(+dim) acute myeloid leukemia presenting with severe hypercalcemia and lumbar spine fracturesNikolaos C Giannakoulas, Evangelos Terpos, Maria Palassopoulou, et al.
JSES Reviews, Reports, and Techniques|May 6, 2024
Delayed diagnosis of a primary diffuse large B-cell lymphoma of the humeral head, presenting as pathological fracture: a case report and review of the literatureAndreas Panagopoulos, Konstantina Solou, Argiris Symeonidis, et al.
British Journal of Haematology|September 9, 2004
Impaired generation of bone marrow CD34-derived dendritic cells with low peripheral blood subsets in patients with myelodysplastic syndromeIlina Micheva, Eleni Thanopoulou, Sotiria Michalopoulou, et al.
Oncology|February 17, 2005
Increased serum CA-15.3 levels in patients with megaloblastic anemia due to vitamin B12 deficiencyArgiris Symeonidis, Alexandra Kouraklis-Symeonidis, Dimitris Apostolopoulos, et al.
Clinical Nuclear Medicine|October 4, 2013
(99m)Tc sestamibi as a prognostic factor of response to first-line therapy and outcome in patients with malignant lymphomaTrifon J Spyridonidis, Panayota Matsouka, Argiris Symeonidis, et al.
JIMD Reports|October 14, 2014
Severe impairment of regulatory T-cells and Th1-lymphocyte polarization in patients with Gaucher diseaseChristos Sotiropoulos, George Theodorou, Constantina Repa, et al.
Gene|August 7, 2020
LRF/ZBTB7A conservation accentuates its potential as a therapeutic target for the hematopoietic disordersVasiliki Chondrou, Georgios S Markopoulos, George P Patrinos, et al.
Annals of Hematology|September 1, 2005
Inappropriately low erythropoietin response for the degree of anemia in patients with noninsulin-dependent diabetes mellitusArgiris Symeonidis, Alexandra Kouraklis-Symeonidis, Agathoklis Psiroyiannis, et al.
Dermatologic Therapy|February 17, 2021
Rare lobular capillary hemangioma associated with azacitidine in high-risk myelodysplastic syndrome patientKaterina Grafanaki, Alexandra Kourakli, Ilias Skeparnias, et al.
Hematology (Amsterdam, Netherlands)|January 20, 2017
Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western GreeceChristina Avgerinou, Ioanna Giannezi, Stela Theodoropoulou, et al.
Pageof 14